Next in Health
A weekly healthcare podcast series hosted by PwC's Health Research Institute that addresses industry trends and timely health policy topics impacting patients, providers, payers, pharmaceutical and life sciences companies as well as vendors and new entrants.
Next in Health
The year in Deals: Preparing for 2024
Tune in to hear PwC Deals leaders discuss preparing for deals in 2024, exploring the current state of the deals market and sharing valuable insights from their newly released 2024 deals outlook. Key topics include:
- Fundamental changes and strategy trends for 2024 and how it’s shaping the health services and pharma landscapes
- The role of the regulators and their impact on deals
- Business model reinvention and the use of new technology to acquire better data and how it’s shaping the deals environment for 2024
- What’s on the horizon: Key success factors for good deal making in 2024
Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.